Case Study: Shanghai Changjiang Science and Technology Development Co. Ltd. improves stroke risk diagnosis and treatment prediction with IBM Watson

Harnessing the power of AI to prevent strokes and build a healthier China

Shanghai Changjiang Science and Technology Development Co. Ltd., an IBM Business Partner, faced the challenge of helping Chinese medical providers screen and treat strokes more effectively as cerebrovascular diseases became more common. Using IBM Watson technology, the company set out to build an AI-based medical assessment platform to identify high-risk patients and support better treatment decisions.

IBM helped Shanghai Changjiang Science and Technology Development Co. Ltd. develop an intelligent stroke assessment and management platform using IBM Watson Studio and IBM API Connect. The solution improved diagnostic accuracy for stroke risk by 15% and achieved 80.89% accuracy in predicting rehabilitation outcomes, while expanding screenings to reach more people earlier.

Shanghai Changjiang Science and Technology Development Co. Ltd.

Zhang YuYu

General Manager